Devalingam Mahalingam, MD, PhD
Disclosures: Grant or research support-AMGEN|Grant or research support-Oncolytics (Relationship has ended)|Grant or research support-Merck and Company, Inc.|Advisor-Qurient|Advisor-OncoOne|Speakers Bureau-Exelisis|Speakers Bureau-Bristol-Myers Squibb|Speakers Bureau-Eisai, Inc.|Consulting Fee-Amgen (Relationship has ended) - 07/11/2022
No Bio Available.